Total extracellular surfactant is increased but abnormal in a rat model of gram-negative bacterial pneumonia.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  American Journal of Physiology - Lung cellular and Molecular Physiology

• Publication date

  2002-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/AJPLUNG.00071.2002PMID 12169586
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hospital-acquired pneumonia: Overview of the current state of the art for prevention and control

  2005cited by this paper
• Lung Surfactants: Basic Science and Clinical Applications

  2002cited by this paper
• Component-specific surface and physiological activity in bovine-derived lung surfactants.

  2002cited by this paper
• P. carinii induces selective alterations in component expression and biophysical activity of lung surfactant.

  2000cited by this paper
• Capsular Polysaccharide and O-Specific Antigen Divergently Modulate Pulmonary Neutrophil Influx in anEscherichia coli Model of Gram-Negative Pneumonitis in Rats

  2000influential reference
• Novel Phospholipase A Activity Secreted byLegionella Species

  2000cited by this paper
• Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC.

  2000cited by this paper
• Acid aspiration increases sensitivity to increased ambient oxygen concentrations.

  2000cited by this paper
• Multiple Mechanisms of Lung Surfactant Inhibition

  1999cited by this paper
• Cytokine-induced airway epithelial ICAM-1 upregulation: quantification by high-resolution scanning and transmission electron microscopy.

  1999influential reference
• Pulmonary surfactant in health and human lung diseases: state of the art.

  1999cited by this paper
• Additivity of protein and nonprotein inhibitors of lung surfactant activity.

  1998cited by this paper
• Surfactant protein A and surfactant protein D in health and disease.

  1998influential reference
• Surfactant and acute lung injury.

  1998cited by this paper
• Surfactant protein A and surfactant protein D in health and disease.

  1998cited by this paper
• Characterizing alterations in the pulmonary surfactant system in a rat model of Pseudomonas aeruginosa pneumonia.

  1998influential reference
• Surface properties, morphology and protein composition of pulmonary surfactant subtypes.

  1996cited by this paper
• Surfactant: a review of its functions and relevance in adult respiratory disorders.

  1996cited by this paper
• The O4 specific antigen moiety of lipopolysaccharide but not the K54 group 2 capsule is important for urovirulence of an extraintestinal isolate of Escherichia coli

  1996cited by this paper
• Surfactant treatment in experimental Escherichia coli pneumonia

  1996cited by this paper
• Surfactant content in children with inflammatory lung disease.

  1996cited by this paper
• Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema.

  1996influential reference
• Immunomodulatory Functions of Surfactant

  1995influential reference
• Extracellular metabolism of pulmonary surfactant: the role of a new serine protease.

  1995cited by this paper
• Pulmonary surfactant subtype metabolism is altered after short-term ozone exposure.

  1995cited by this paper
• Pulmonary surfactant subfractions in patients with the acute respiratory distress syndrome.

  1995cited by this paper
• The presence of K54 capsular polysaccharide increases the pathogenicity of Escherichia coli in vivo.

  1994cited by this paper
• Changes in subphase aggregates in rabbits injured by free fatty acid.

  1994cited by this paper
• Surface-area cycling of different surfactant preparations: SP-A and SP-B are essential for large-aggregate integrity.

  1994cited by this paper
• Surfactant proteins A and D.

  1994cited by this paper
• Surfactant and the adult respiratory distress syndrome.

  1993cited by this paper
• Generation of isogenic K54 capsule‐deficient Escherichia coli strains through TnphoA‐mediated gene disruption

  1993cited by this paper
• An overview of nosocomial infections, including the role of the microbiology laboratory

  1993cited by this paper
• Decreased surfactant protein A in patients with bacterial pneumonia.

  1993cited by this paper
• Inhibition of pulmonary surfactant by oleic acid: mechanisms and characteristics.

  1992cited by this paper
• Inhibition of surfactant subtype convertase in radiation model of adult respiratory distress syndrome.

  1991cited by this paper
• Inhibition of pulmonary surfactant function by phospholipases.

  1991cited by this paper
• Fractal perspectives in pulmonary physiology.

  1991cited by this paper
• Clearance and recycling of pulmonary surfactant.

  1990cited by this paper
• Nosocomial pneumonia in the 1990s: update of epidemiology and risk factors.

  1990cited by this paper
• Molecular comparison of a nonhemolytic and a hemolytic phospholipase C from Pseudomonas aeruginosa

  1990cited by this paper
• Altered surfactant function and metabolism in rabbits with acute lung injury.

  1990cited by this paper
• Nonlinear optical investigation of the bulk ferroelectric polarization in a vinylidene fluoride/trifluoroethylene copolymer

  1989cited by this paper
• Proteolytic inactivation of dog lung surfactant-associated proteins by neutrophil elastase.

  1989cited by this paper
• Surfactant subtypes in mice: characterization and quantitation.

  1989cited by this paper
• Pathogens causing nosocomial infections preliminary data from the national nosocomial infections surveillance system

  1988cited by this paper
• Epidemiology of hospital-acquired pneumonia.

  1987cited by this paper
• Epidemiology of hospital-acquired pneumonia.

  1987cited by this paper
• Surfactant abnormality after endotoxin-induced lung injury in guinea-pigs.

  1987cited by this paper
• Diagnosis of nosocomial pneumonia in intubated, intensive care unit patients.

  1987cited by this paper
• Metabolism and turnover of lung surfactant.

  1987cited by this paper
• Effects of hemoglobin and cell membrane lipids on pulmonary surfactant activity.

  1987cited by this paper
• Surface property changes from interactions of albumin with natural lung surfactant and extracted lung lipids.

  1985cited by this paper
• Protein composition of rabbit alveolar surfactant subfractions.

  1984cited by this paper
• Changes in fatty acids in phospholipids of the bronchoalveolar fluid in bacterial pneumonia and in adult respiratory distress syndrome.

  1984cited by this paper
• Subfractionation of lung surfactant. Implications for metabolism and surface activity.

  1983cited by this paper
• Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol.

  1982cited by this paper
• Microdetermination of Phosphorus

  1979cited by this paper
• Principles and practice of infectious diseases. Vols 1 and 2.

  1979cited by this paper
• Effect of endotoxin on rabbit alveolar phospholipids.

  1976cited by this paper
• Effect of pulmonary pathogens on surfactant.

  1968cited by this paper
• A rapid method of total lipid extraction and purification.

  1959cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• In-Vitro and In-Vivo Antibacterial Effects of Frankincense Oil and Its Interaction with Some Antibiotics against Multidrug-Resistant Pathogens

  2022cites this paper
• Remote ischemic preconditioning attenuates cardiopulmonary bypass-induced lung injury

  2017cites this paper
• Chapter 10 – Acute Respiratory Distress Syndrome

  2017cites this paper
• Characterization of surfactant alterations in pigs infected with Actinobacillus pleuropneumoniae

  2016cites this paper
• Improving of Antibacterial Activity for Antibiotics by Purified and Characterized Lectin from Acinetobacter baumannii

  2015cites this paper
• Requirement for Serratia marcescens Cytolysin in a Murine Model of Hemorrhagic Pneumonia

  2014cites this paper
• Endogenous expression pattern of resolvin D1 in a rat model of self-resolution of lipopolysaccharide-induced acute respiratory distress syndrome and inflammation.

  2014cites this paper
• Osthole protects lipopolysaccharide-induced acute lung injury in mice by preventing down-regulation of angiotensin-converting enzyme 2.

  2013cites this paper
• Surfactant

  2013cites this paper
• Fetal and neonatal samples of a precursor surfactant protein B inversely related to gestational age

  2013cites this paper
• Lipopolysaccharide-Induced Acute Lung B and Integrin Signal during κ NF-Tyrosine Kinases Mediate Activations of

  2013cites this paper
• Inhibition of pulmonary nuclear factor kappa-B decreases the severity of acute Escherichia coli pneumonia but worsens prolonged pneumonia

  2013cites this paper
• The Future of Exogenous Surfactant Therapy

  2011cites this paper
• Surfactant therapy for acute lung injury and acute respiratory distress syndrome.

  2011cites this paper
• Resolvin D1 protects mice from LPS-induced acute lung injury.

  2011cites this paper
• Surfactant Therapy of ALI and ARDS

  2011cites this paper
• Development of enzyme-linked immunosorbent assay for bovine surfactant protein D in bronchoalveolar lavage fluid.

  2010cites this paper
• Surfactant Protein D Interacts with α2-Macroglobulin and Increases Its Innate Immune Potential*

  2010cites this paper
• 7. PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES)

  2009cites this paper
• Penicillin-binding protein 7/8 contributes to the survival of Acinetobacter baumannii in vitro and in vivo.

  2009cites this paper
• Systems Biology and Bioinformatics in Medical Applications

  2009cites this paper
• Capsular polysaccharide and the O-specific antigen impede antibody binding: a potential obstacle for the successful development of an extraintestinal pathogenic Escherichia coli vaccine.

  2009cites this paper
• Sustained hypercapnic acidosis during pulmonary infection increases bacterial load and worsens lung injury*

  2008cites this paper
• Long-term exposure to LPS enhances the rate of stimulated exocytosis and surfactant secretion in alveolar type II cells and upregulates P2Y2 receptor expression.

  2008cites this paper
• Surfactant for pediatric acute lung injury.

  2008cites this paper
• Long-term exposure to LPS enhances the rate of stimulated exocytosis and surfactant secretion in alveolar type II cells and upregulates P 2 Y 2 receptor expression

  2008cites this paper
• Hypercapnic Acidosis Attenuates Lung Injury Induced by Established Bacterial Pneumonia

  2008cites this paper
• Peripheral cell wall lipids of Mycobacterium tuberculosis are inhibitory to surfactant function.

  2008cites this paper
• Hypercapnic acidosis attenuates severe acute bacterial pneumonia-induced lung injury by a neutrophil-independent mechanism*

  2008cites this paper
• Rat Pneumonia and Soft-Tissue Infection Models for the Study of Acinetobacter baumannii Biology

  2008cites this paper
• Src Tyrosine Kinases Mediate Activations of NF-κB and Integrin Signal during Lipopolysaccharide-Induced Acute Lung Injury1

  2007cites this paper
• CAPSULE AND O-ANTIGEN FROM AN EXTRAINTESTINAL ISOLATE OF ESHERICHIA COLI MODULATE CYTOKINE LEVELS IN RAT MACROPHAGES IN VITRO AND IN A RAT MODEL OF PNEUMONIA

  2007cites this paper
• Surfactant dysfunction and lung injury due to the E. coli virulence factor hemolysin in a rat pneumonia model.

  2007cites this paper
• Extraintestinal Pathogenic Escherichia coli Survives within Neutrophils

  2007cites this paper
• A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate.

  2007cites this paper
• Injury Lipopolysaccharide-Induced Acute Lung B and Integrin Signal during κ NF-Src Tyrosine Kinases Mediate Activations of

  2007cites this paper
• Surfactant alterations in acute inflammatory lung injury from aspiration of acid and gastric particulates.

  2005cites this paper
• Nonspecific Interstitial Pneumonia, Alveolar Proteinosis, and Abnormal Proprotein Trafficking Resulting from a Spontaneous Mutation in the Surfactant Protein C Gene

  2005cites this paper
• Hypercapnic acidosis does not modulate the severity of bacterial pneumonia–induced lung injury

  2005cites this paper
• E. coli virulence factor hemolysin induces neutrophil apoptosis and necrosis/lysis in vitro and necrosis/lysis and lung injury in a rat pneumonia model.

  2005influential citation
• Roles for early response cytokines during Escherichia coli pneumonia revealed by mice with combined deficiencies of all signaling receptors for TNF and IL-1.

  2004cites this paper
• Gastric acid and particulate aspiration injury inhibits pulmonary bacterial clearance

  2004cites this paper
• Chlamydia pneumoniae affect surfactant trafficking and secretion due to changes of type II cell cytoskeleton.

  2003cites this paper